Qlarix launches its risk-based oversight system after a successful pilot with biopharma
The increasing complexity of clinical trials and evolving regulatory requirements pose significant challenges for Sponsors, CROs and Research Entities.
Traditional monitoring approaches are often resource-intensive and reactive, detecting issues too late in the process. This leads to costly delays, compromised data quality, and regulatory concerns.
Clinical teams frequently struggle with inefficient oversight strategies, which force them to spread resources thin across all study areas instead of focusing on critical risks. Without real-time risk detection and proactive management, trials are at greater risk of deviations that could negatively impact study integrity and outcomes.
The Solution: Smarter, Risk-Based Oversight with WiseCLIN
To address these challenges, Qlarix has launched WiseCLIN, a risk-based oversight (RBOS) system based on Risk-Based Quality Management (RBQM) methodology, designed to help trial teams anticipate risks, optimize resources, and prevent deviations before they escalate.
Unlike traditional oversight methods, WiseCLIN enables clinical trials stakeholders to shift from reactive to proactive oversight, ensuring that critical risks are identified and mitigated early. The system’s real-time risk alerts provide actionable insights, supporting timely decision-making and continuous trial improvement.
By prioritizing high-risk areas, WiseCLIN allows trial teams to focus on what truly matters, enhancing data quality and operational efficiency while reducing administrative burdens.
Proven Success: WiseCLIN in Action
A successful pilot phase with biopharmaceutical companies demonstrated that WiseCLIN improves risk detection, streamlines oversight, and reduces inefficiencies. Feedback from our industry partners has been essential in refining the system to meet the dynamic needs of clinical research.
At Qlarix, we are committed to driving innovation in clinical trial oversight. WiseCLIN is already transforming study management, helpng Sponsors, CROs and Research Entities work smarter, reduce uncertainty, and improve trial outcomes.
Discover how WiseCLIN can optimize your trials. Learn more at www.qlarix.com .